default author photo

Timothy Haystead

Duke University - Department of Pharmacology and Cancer Biology

SCHOLARLY PAPERS

2

DOWNLOADS

88

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

Targeting Borrelia Burgdorferi HtpG with a Berserker Molecule, A Novel Paradigm for Anti-Microbial Development

Number of pages: 58 Posted: 13 Jan 2023
Duke University - Department of Pharmacology and Cancer Biology, University of North Carolina (UNC) at Chapel Hill - Department of Biochemistry and Biophysics, University of North Carolina (UNC) at Chapel Hill - Division of Oral and Craniofacial Health Sciences, Duke University - Department of Pharmacology and Cancer Biology, Duke University - Department of Pharmacology and Cancer Biology, Duke University - Department of Pharmacology and Cancer Biology, Duke University - Department of Pharmacology and Cancer Biology, Duke University - Department of Pharmacology and Cancer Biology, Duke University - Department of Pharmacology and Cancer Biology, Stanford University - Sarafan ChEM-H Institute, Stanford University - Sarafan ChEM-H Institute, University of Delaware - Delaware Biotechnology Institute, University of Delaware - Delaware Biotechnology Institute, University of Delaware - Delaware Biotechnology Institute, Tulane National Primate Research Center - Department of Microbiology and Immunology, Galaxy Diagnostics, Inc., Stanford University - Sarafan ChEM-H Institute, University of North Carolina (UNC) at Chapel Hill - Department of Biochemistry and Biophysics, Duke University - Department of Pharmacology and Cancer Biology and Duke University - Department of Pharmacology and Cancer Biology
Downloads 55 (1,010,164)

Abstract:

Loading...

HtpG inhibitor, Borrelia burgdorferi, heat shock protein, chaperone, verteporfin, Lyme disease, Hsp90, antibiotic discovery.

2.

Oral Hsp90 Inhibitor, SNX-5422, Attenuates SARS-CoV-2 Replication and Dampens Inflammation in Airway Cells

Number of pages: 66 Posted: 12 Mar 2021
Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Department of Pharmacology and Cancer Biology, Duke University - Division of Pulmonary, Allergy and Critical Care Medicine, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Division of Pulmonary, Allergy and Critical Care Medicine, Duke University - Department of Pharmacology and Cancer Biology, Duke University - Duke Human Vaccine Institute and Duke University - Department of Molecular Genetics and Microbiology
Downloads 33 (1,277,121)

Abstract:

Loading...

COVID-19, SARS-CoV-2, Hsp90, Post-exposure prophylaxis, anti-inflammatory, host directed therapy, orally bioavailable